Does incidental CAC quantified on routine nonelectrocardiography-gated CT using a deep-learning algorithm provide CV risk stratification beyond traditional risk prediction methods?
Get the answer in #JACC: https://t.co/WiGpyXZGRW #cvPrev
NOW at #ACC2023#FLAME high-risk #PE registry results
🔥@InariMedical FT pts w 1.9% in-hospital mortality
🔥Context arm consistent w hx data 29.5% in-hospital mortality
🔥Trial stopped early due 2 overwhelmingly meeting pre-defined PGs @ interim
Unheard of. Practice changing
Well, it’s Tuesday and as good a day as any to publish simultaneously in JAMA & JAMA Cardiology. A smorgasbord of +ve renal denervation data for you:
Congrats to a brilliant team of authors, led by Michel Azizi & @ajaykirtane
https://t.co/iMSGWi947q
https://t.co/mUXBccqxOn
Brave new world of #ArtificialIntelligence (AI) guided #YesCCT & #CAD? #AI evaluation of CCTA (AI-QCT) enabled rapid & accurate ID + exclusion of high-grade coronary artery stenosis w/ close agreement to invasive cath by QCA. https://t.co/vn7iMaYmKs
#JACCIMG #cvCAD #CardioTwitter @AChoiHeart@jayearls
Dang man.
“I will not whine or complain during the process. I won't be a distraction, on or off the field… I may make mistakes along the way. I won't retire with a perfect passer rating or zero career interceptions. But I'll try as hard as anybody.”
Voted on by their teammates 👏
Congrats to @PatrickMahomes and @isiah_pachecoRB, this year's Derrick Thomas MVP and Mack Lee Hill Rookie of the Year award winners.
🧵 New @AHAScience Statement on Surgical Management and Mechanical Circulatory Support in High Risk Acute PE!
Presented today #STS2023 by Writing Chair @GoldbergJBCTMD from @WestchesterMed & published in @CircAHA:
https://t.co/YjeA8QbHOw
Endorsed by @STS_CTsurgery @ @AATSHQ
“How then can we reconcile the concept of ‘letting go of the outcome’ with our fundamental desire and commitment to making patients feel better and live longer?”—Bhagavad Gita, Dichotomy of Control, and Metric Medicine: The Conflict of Burnout, out in EHJ. https://t.co/cPKQfubVWr
Important new data for individualized prev. in asymptomatic pts by #YesCCT: The Miami Heart Study, the largest-to-date cohort in the US to evaluate #CAC & CCTA-based plaque burden finds nearly 50% w/ plaque, including 16% w/ CAC=0. https://t.co/Y8q081S53x
#JACCIMG#cvPrev#ASCVD
Among stable CP, CAD prevalence of 13% despite CAC=0, I'm not sure I would be satisfied with #powerofzero, event rates may be low, but that's a substantial number of people who may benefit from statin and aggressive RF modif @AliAghaBCM@JACCJournals https://t.co/wx5U4w1mEF
In this analysis of patients who underwent ultrasound renal denervation in the RADIANCE-HTN SOLO trial, the blood pressure reductions were sustained throughout the 36 months of follow-up, with patients on a stable number of antihypertensive medications. https://t.co/eK7C4Px3hA
Big week for patients with hypertension…congratulations to all at @ReCorMedical on the success of RADIANCE II. Another positive sham-controlled blinded study of renal denervation for HT. https://t.co/Vpw2HFaqxk
@JanetWeiMD
Promise: More women were likely to have + stress test, could be due to mvd, 2/3 of cardiac events in non instructive CAD
❤️Women with nonobstructive CAD on CTA have worse MACE
❤️Primary prevention risk scores underestimate risk in women #SCCT2022